Canada markets open in 3 hours 11 minutes

Biomerica, Inc. (BMRA)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
3.7700+0.1400 (+3.86%)
At close: 04:00PM EST
3.7700 0.00 (0.00%)
After hours: 04:00PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close3.6300
Bid2.6200 x 800
Ask4.0000 x 1100
Day's Range3.5800 - 4.0400
52 Week Range2.5600 - 5.2500
Avg. Volume90,634
Market Cap50.622M
Beta (5Y Monthly)-0.53
PE Ratio (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    Biomerica InFoods® IBS Data Presented at the 2022 American College of Gastroenterology (ACG) Annual Scientific Meeting

    ACG Presidential Award Received for the InFoods® IBS Data Presented at the American College of Gastroenterology (ACG) Annual Scientific MeetingThe Presented Clinical Study Data Showed InFoods® IBS Provided Significant Improvement in Several IBS Symptoms Including Abdominal Pain Intensity (API), Which, in Some Cases, Were Better Than Current Drugs in the MarketInFoods® IBS Clinical Research Data Is Also Featured in Medscape and Gastroenterology Advisor, two leading Medical Trade and News Publicat

  • GlobeNewswire

    Walmart to Expand Sales of Biomerica’s Aware® Breast Self Exam; Product will now be available in over 2400 Walmart stores

    Simple at-home device to increase sensitivity in breast self-examsEarly detection of breast cancer saves livesAbout 80% of breast cancer is detected by women themselves who notice changes in their breast IRVINE, Calif., Oct. 14, 2022 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) (the “Company”) today announced that under a General Merchandise Supplier Agreement with Walmart, the Company’s Aware® Breast Self Exam device will now be sold in over 2400 Walmart’s retail stores. In July, the Comp

  • GlobeNewswire

    Biomerica Reports 30% Increase in Revenues for Fiscal Q1 2023 vs. Fiscal Q1 2022

    Notice of Patent Allowance in Australia containing broad claims pertaining to treating ADD/ADHD using the InFoods® Technology Notice of Patent Allowance in Japan containing broad claims pertaining to treating Depression using the InFoods® Technology IRVINE, Calif., Oct. 13, 2022 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced medical products, today reported net sales for the three months ended August 31, 2022 of $1.67 million, versus net sales of $1.26 million